HighTower Advisors »

Summit Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $226k 11k 20.66
2025-06-30 $838k 39k 21.28
2025-03-31 $756k 39k 19.29
2024-12-31 $702k 39k 17.85
2024-09-30 $883k 40k 21.89
2024-06-30 $305k 39k 7.81
2024-03-31 $265k 64k 4.14
2023-12-31 $31k 12k 2.59